Virtu Financial’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Virtu Financial’s Portfolio BLPH Stock Details BLPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-25,870	Closed	-$18K	–	2235
2023 Q2	$18K	Buy	+25,870	New	+$167K	﹤0.01%	1285
2021 Q3	–	Sell	-16,495	Closed	-$80K	–	2360
2021 Q2	$80K	Buy	+16,495	New	+$74K	0.01%	1252
2019 Q4	$27K	Buy	5,133 +2,531	+97%	+$16.1K	﹤0.01%	1285
2019 Q3	$19K	Buy	2,602 +1,597	+159%	+$14.6K	﹤0.01%	1298
2019 Q2	$9K	Sell	1,005 -94	-9%	-$901	﹤0.01%	1389
2019 Q1	$11K	Sell	1,099 -1,348	-55%	-$14.9K	﹤0.01%	1339
2018 Q4	$29K	Buy	2,447 +920	+60%	+$13.4K	﹤0.01%	1343
2018 Q3	$25K	Buy	1,527 +180	+13%	+$4.28K	﹤0.01%	1386
2018 Q2	$49K	Buy	+1,347	New	+$46.6K	﹤0.01%	1756
2018 Q1	–	Sell	-3,771	Closed	-$146K	–	2934
2017 Q4	$146K	Buy	+3,771	New	+$98.8K	0.01%	1799

Other funds holding BLPH

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu Financial's BLPH Position: Q3 2023 in Review

Virtu Financial sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q3 2023, closing a stake of 25,870 shares — an estimated $18K sold.

Virtu Financial first reported a position in BLPH in Q4 2017 and held it in 10 quarters. The position peaked at $146K in Q4 2017. 22 funds tracked by Wall St. Rank hold BLPH as of Q3 2023.

Virtu Financial reported no remaining Bellerophon Therapeutics, Inc. position as of Q3 2023 after selling out during the quarter.
Virtu Financial sold 25,870 Bellerophon Therapeutics, Inc. shares in Q3 2023, an estimated $18K.
Virtu Financial first reported a position in Bellerophon Therapeutics, Inc. in Q4 2017 and held it in 10 quarters.
Virtu Financial's Bellerophon Therapeutics, Inc. position peaked at $146K in Q4 2017.
22 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q3 2023.

Based on Virtu Financial's 13F filing for Q3 2023, filed 15 Nov 2023.